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Abstract 
Genetic studies report the existence of a mutant allele ~32 of CCR5 chemokine re-
ceptor gene at high allele frequencies (rvlO %) in Caucasian populations. The presence of 
this allele is believed to provide partial or full resistance to HIV. In this study, we look 
at the impact of education, temporarily effective vaccines and therapies on the dynam-
ics of HN in homosexually active populations. In our model, it is assumed that some 
individuals possess an allele (like ~32 of CCR5) that prevents the successful invasion 
or replication of HN. Our model therefore differentiates by genetic and epidemiological 
status and naturally ignores the reproduction process. Furthermore, HIV infected individ-
uals are classified as rapid, normal or slow progressors. In this complex setting, the basic 
reproductive number ~o is derived in various situations. The separate or combined effect 
of therapies, education and vaccines are analyzed. Our results support the conclusions 
of Shu-Fang Hsu Schmitz that some integrated intervention strategies are far superior to 
those based on a single approach . 
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Background 
The human immunodeficiency viruses (HIV-1 and HIV-2), are pathogens that causes the deadly 
disease of the acquired immune deficiency syndrome (AIDS). The origins of these viruses, HIV-1 
and HIV-2 are not known, but the first known cases in the U.S were reported in gay men from 
San Francisco in 1981. Even though HIV is considered to be a relatively young disease, evidence 
has shown a case of HIV-1 positive from Zaire in 1959. Some evolutionary biologist belief that 
the virus was first transmitted to humans from monkey viruses. Humans, transmitted the 
disease mainly through sexual intercourse and intravenous drug users. During the 1980's and 
1990's two waves of HIV infection emerged: one among heterosexual men and women in Africa, 
and two among homosexual men and intravenous drug users in the U.S, as well as in Europe. 
The rates of HIV infection in Africa are very high compared to U.S and Europe. Currently, 
AIDS is the fourth leading cause of death globally and the leading cause in Africa. For the 
year 1996, approximately 23 million people were HIV positive world wise. As of today, 36 
million people have been reported to be HIV positive worldwide [14]. These shows a difference 
of approximately 13 million new infecteds, which shows the rapid transmission of HIV. [14] 
HIV specifically targets the "white blood" cells, i.e helper T cells. Helper T cells are vital for 
the function of the immune system since their job is to activate killer T cells to destroy anything 
that is foreign to the human body. HIV attaches itself to the CD4 protein (a receptor) from the 
helper T cells, and once there it uses the host cell's enzymatic machinery to reproduce, and grow. 
Once the HIV is inside the host cell, the virus uses reverse transcriptase to copy its RNA genome 
into double stranded DNA molecules. This double helix enters the host cell's nucleus, where 
the virus genome integrates into the host chromosome. In most cases, this infected chromosome 
replicates two new infective cells for each cell division. The immune system responds to HIV 
infection by destroying the virions floating on the bloodstream, or by killing its own infected T 
cells. The life cycle and gene composition of HIV-2 is very similar to that of HIV-1. Yet HIV-2 
is much more benign and has a much lower mutation rate than HIV -1 's reverse transcriptase. 
[21] In this research we are only working with the human immunodeficiency virus-1. 
HIV does not kill people directly or quickly; instead, the destruction of CD4+ T cells 
weakens the immune system. Reverse transcription is high error prone and T cells are not able 
to recognize all of the altered epitotes in order to destroy them. This is because the immune 
system is limited to recognize certain proteins or epitotes as foreign. HIV is constantly changing 
its epitotes because the virus uses reverse transcription for its reproduction. Consequently, the 
immune system is not able to keep up with all the mutations, and the virions overturn the T 
cells, in the long run the immune system collapses. This is the last of a three-phase sequence of 
AIDS. In the first phase, 30% of those infected, the person presents symptoms of skin rashes and 
fever, but this only lasts a few weeks. The duration of the second phase has an average of ten 
years. In this phase, T cells and HIV are constantly fighting for survival, but as time progresses 
the number ofT cells continues to decline from a "normal level of about 1,000 cells/milliliter 
of blood to only 200 cells/mL." It is at this threshold that infected individuals enter the third 
AIDS phase. The disintegration of the immune system happens because it can no longer defend 
itself against other bacterial and fungal pathogens, especially when most T cells are dead or 
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infected by the virus. The expected life for individuals in this phase is about 2 years. [21] 
The devasting global impact of HIV has increased research efforts to find an effective vaccine, 
or drugs that would stop the progression and transmission rate of HIV. These efforts have been 
mildly successful since HIV evolves resistance to drugs and mutates extremely fast. Recent 
genetics studies indicate a correlation of mutant genes in HIV co-receptors that may provide 
protection against HIV. This gives us the hope that researchers may be able to develop a drug 
that may mimic the resistant gene or that gene therapy may be useful in preventing HIV. This 
"insertion' of a resistant gene might be able to stop the HIV infection from progressing to 
AIDS, and therefore lowering the transmission rates of HIV /AIDS . 
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1 Introduction 
Recent genetic studies observed that many individuals with multiple exposure to HIV-1 remain 
seronegative, while others continue to be infected by HIV-1. Researchers have correlated these 
findings with some mutant genes in HIV co-receptors. Studies found the presence of mutant 
alleles such as Ll32 and m303 of CCR5 suggesting resistance or protection against HIV for 
some individuals. Our interest lies precisely on these mutant alleles and the receptors from the 
host's cell and the virus's cell. It seems that mutant alleles have somehow change the structure 
of the helper T cells in a way that it is very difficult for the virus' receptor to connect to 
it. Hence, the virus stops replicating and individuals show a resistant to HIV. According to 
the findings, the mutant alleles seem to provide full protection against HIV in homozygotes, 
and partial resistance for heterozygotes. These results were observed in about 10% of the 
Caucasian population. For Hsu Schmitz [2] these conclusions indicated the "existence of genetic 
heterogeneity with respect to susceptibility to HIV infection and to rate of AIDS progression 
in general populations". Therefore, using this inference Hsu Schmitz investigated the impact 
of genetic heterogeneity via a deterministic model for homosexually active population. Hsu 
Schmitz concluded that giving treatment and vaccination to patients was helpful in reducing 
the transmission rate, but they were not helpful if they were implemented alone. This project 
starts from Hsu Schmitz's basic ideas and model. A similar model is constructed in which 
a susceptible population is subject to vaccination, education and treatment. Our primary 
goal is to investigate the effects of education, temporary vaccination and treatment on HIV 
transmission in a homosexually active population with genetic heterogeneity. 
Vaccination and treatment are not efficient control methods. Vaccines in development may 
only give a temporary immunity to HIV /AIDS. Antiviral drugs used in treatment such as AZT 
(zidovudine), ddc( dideoxycytidine), and ddl( dideosyinosine) also worked temporarily. Theses 
antiviral drugs blocks the replication of the virus. However, the virus's high rate of mutation 
eventually catches on. Those two methods are costly both at the individual and population 
level. Hence, education may be the key factor in altering the course of this detrimental world 
pandemic. In our model, education means that individuals are encouraged to use condoms, 
or have fewer partners. Abstinence and safe sexual behavior are also involved. This paper 
is divided into the following sections. Section 2 explains the complex model and includes the 
diagram of the compartmental model which illustrates the dynamics of the population under 
study. Section 3 explains in great detail the different cases for the reproductive number, Ro. 
Conclusions and final thoughts are in Section 4. Acknowledgments are given in Section 5 . 
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2 The Complex Model 
Following Hsu Schmitz [1] we classify the homosexually active population into three classes of 
susceptible individuals: no resistant (S1), partially resistant (52 ) and fully resistant (53) to HIV 
infection. Infected individuals are classified as rapid (!1), normal (lz) and slow (!3) progressors. 
Throughout this paper, the index i refers to the non infected groups, i.e.susceptible, vaccinated 
and educated individuals and the index j refers to infected classes capable of transmitting the 
disease, i.e.,infected and treated individuals. In this model we assume that AIDS patient are 
sexually inactive, hence, AIDS patients do not affect the HIV process. 
As in Hsu Schmitz (1999), we assume that recruitment occurs at a constant rate, 1r. The 
three susceptible groups get the respective fixed fractions, 9i (i = 1,2,3 and ~i9i = 1), 
which are related to the frequencies of relevant genotypes. Although genotype frequencies 
usually change with time due to random fluctuation and/or to disease, the frequencies in a 
homosexually population will have little effect on new recruits, hence we ignore them. Because 
in general the frequencies of mutant alleles are relatively small, it is expected and reseanable 
to assume that 
(1) 
that is, most individuals have no resistance, a small fraction have partial resistance, and an even 
smaller fraction have complete resistance. All individuals are subject to the common per-capita 
natural removal rate, fL· 
The average number of partners per unit time is denoted by c; (i = 1, 2, 3) for Si-individuals 
and for Irindividuals. As in Hsu Schmitz's paper we assume that genetic heterogeneity does 
not influence pairing behavior because most individuals do not know their genotypes at loci 
related to HIV susceptibility and/or AIDS pathogenesis. Furthermore, we assume that all 
individuals of a given disease status have the same average number of partners per unit time, 
i.e., ci = c for all i. To make the model simpler, as Hsu Schmitz we further assume that disease 
status does not affect pairing behavior, as in Anderson, Gupta and May (1991), McLean and 
Blower (1993), and Castilla-Chavez, et, al (1989a, b). We follow this same approach. 
The per-capita progression rates for Ii individuals are denoted by 'Yi (j = 1, 2, 3). Because 
1/ri is the average incubation time of Irindividuals, it is obvious that 
'Yl > 'Y2 > 'Y3· (2) 
The infectiousness of Ii individuals is reflected by the per-partnership transmission rate, 
(3i (j = 1, 2, 3). We assume that fast progressors (!1) have the highest viral load, thus are 
most infectious. In addition, slow progressors (!3) have the lowest viral load, hence are least 
infectious. More specifically, we hypothesize the following relation: 
(3) 
It has been shown that the viral load and the infectiousness may change dramatically during 
the incubation period. However, to incorporate this fact we would need to keep track of the 
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"age" of infection of each individual and end up with a complicated model [22]. For the sake of 
simplicity, here we assume f3j are constant as in Anderson, Gupta and May (1991), in McLean 
and Blower (1993) and Castilla-Chavez, et, al (1989a, b). 
During the partnership between an 5 2-individual and an Irindividual (j=2,3), the trans-
mission rate f3j of the infected partner is reduced to xjf3j, with 0 < Xj < 1 to account for 
partial resistance to HIV in 52-individuals. Newly infected 5i-individuals (i = 1, 2) join the 
three infected groups with respective proportions ji1 , which satisfy: 
3 
0 :::; fij :::; 1 and L fij = 1. (4) 
j=l 
We expect the new infecteds who have no resistance (51) to generate a larger fraction of rapid 
progressors (II) and a smaller fraction of slow (13) progressors than those coming from 5 2 , that 
is, 
(5) 
A certain number of individuals from the susceptible class 5i (i = 1, 2, 3) are assumed to 
be educated at a rate a. A certain proportion (Pi) of newly recruited 5i-individuals is assumed 
to be effectively vaccinated. Moreover a certain number of individuals from the infected Ir 
individuals (j = 1, 2, 3) are assumed to be effectively treated at a rate, (mj) . We assume 
that the transmission rate of effectively treated individuals (T1) is reduced from f3j to a f3j with 
0:::; a< 1, and the progression rate is reduced from '"Yi to Y'"Yi with 0:::; y < 1. The value of 1 is 
not included in the ranges of a and y because it means treatment does not reduce infectiousness 
and rate of progression at all, which does not sound reasonable based on current knowledge. 
As in [10], and [2] we assume that the vaccines have a "take" proportion of E (0 < E < 1), an 
efficacy of~ (0 < ~ < 1) and a protection duration of 1/w units of time. The ranges of E and~ do 
not include 0 and 1 because 0 implies the vaccine is useless and 1 implies the vaccine is perfect; 
both are unrealistic. These vaccine parameters indicate [100 x (1- E)]% vaccinated individuals 
are not effectively vaccinated and they are in principle like other unvaccinated individuals. As 
in [2], those effectively vaccinated individuals (in a proportion of PiE), denoted by Vi, still have 
[100 x (1 - ~)]% chance to be infected within the protection duration of 1/w units of time. 
No reduction in infectiousness is assumed for infecteds who have been vaccinated. Although 
individuals might become more active (i.e., having more sexual partners per unit of time) after 
being treated or vaccinated, for simplicity we assume as in [2] that neither the treatment nor 
the vaccination changes people's pairing behavior, so the common pairing activity c and the 
proportional mixing pattern are still in effect. In addition, we assume that the effectiveness of 
education is given by W and its range does not include 0 and 1 because 0 implies that education 
is useless and 1 implies that education is completely effective. Now, let the total population be 
denoted by 
3 3 
<I>:= L(Vi + 5i + Ei) + 'LU1 + Tj) (6) 
i=l j==l 
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We reparameterize the transmission rates via (3 := (32 , or more specifically, 
(7) 
Relation (3) implies that the multipliers 
(8) 
Currently there are no data that throw light on whether or not the reduction factors Xj for 
(3i depend on j. To continue our goal of analyzing the simplest possible genetic-epidemiological 
model, we assume that Xj = x for all j. 
Then the forces of infection for 5 1 and 52 individuals are 
3 3 
(3 (LJ bi Ii +a L bi Ti)/<I>, 
j=l j=l 
x (Js1, 
for Er and E 2-individuals are 
(JE2 X (JV1 
X (1 - W) (Js1 • 
and for Vi- and "\12-individuals are 
(Jv2 x (Jv1 
X (1 - ~) (JS1 • 
The numbers of newly infected Si-, Vi- and Ei- individuals ( i = 1, 2) are 
8 S; = C Si (} S;, 
8v; = c Vi (JV;' 
8 E; = c Ei (} E;. 
(9) 
(10) 
(11) 
(12) 
(13) 
(14) 
(15) 
(16) 
(17) 
These newly infected individuals enter the jth (j = 1, 2, 3) infected group (Ii and Tj) at the 
rate 
2 
Pi= L fii (8s; + 8v; + 8EJ· (18) 
i=l 
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The mathematical model is described by the following system of equations, where i=1, 2 
and j=1,2,3 : 
Vi - 9i'1fPiE - (p, + w) Vi - DV; 
V3 - g31rp3E - (p, + w) V3 
si - 9i1f(1- PiE)+ wVi- (p, + a)Si - 8si 
Sg = g31r(1- p3E) + wS3 - (p, + a)S3 
Ei - aSi- p,Ei- DEi (19) 
Eg 
-
aS3 - p,E3 
lj - Pi- (p, + mi + li)Ii 
tj - mili- (p, + Yli)Ti 
3 
P(t) - L.:.:cvk + sk + Ek + Ik + Tk) 
k=l 
2.1 Simple model 
For interpretation purposes we first considered a homozygotic population (note that the fre-
quencies of genotypes is equal to 1). By doing so we obtained the following reproductive number 
(where the subscript S denotes "Simple") 
~0 = ~ { f cf3bk + 
s 2 p,+m+l ( 
fcbk/3 ) 2 4 ( jbkcm/3 ) } 
p, + m + 1 + a (J.L + Yl) (p, + m + I) (20) 
where 
k = (1 - _a w) (1 -_P. pE) + (1 - ~) (-p, ) 
p,+a p,+w p,+w 
(21) 
It is worthwhile to notice that k contains only parameters involving education and vacci-
nation. The first two terms denote the reduction factor for education and the proportion of 
non-vaccinated individuals respectively. The other two terms represent the reduction factor for 
vaccination and the proportion of vaccinated individuals respectively. Notice that the range 
of k will always be between 0 and 1, which implies that education and vaccination will always 
reduce the value of ~os. 
For convenience let 
~0 = fcf3bk 
SI p,+m+l 
m 
and ~sT = ---
p, + Y'Y 
by making these substitutions we can write ~s as follows 
~s = ~ ( ~Osr + J~osr (~osr + 4a~osT)) 
9 
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The square root in ~0 represents the 2 step process that a treated person takes before s/he 
can actually generate another treated individual. In order to analyze the value of ~os, we shall 
take its derivative with respect to m and show under what circumstances, 
d~osr < O 
dm 
which implies that increasing treatment lowers ~os. Thus by taking the derivative we obtain 
2ary fcbkj3 
'f/y f-l + m +I 
( )
2 fcbkj3 4afbkcmj3 
+ <0 f..L+m+! (f..l+Y!)(f..L+m+!) 
which gives the following inequality 
(24) 
Hence, treatment will reduce ~Osr· We should start a treatment program, only if it reduces 
the infectivity by at least this factor. Reducing infectivity is more beneficial than letting people 
live longer, since the more an individual lives the more people s/he infects, so the good effect 
of treatment (a) has to outweigh the "bad" effect (y) on the population. Hence, by increasing 
treatment we will be able to lower the value of ~0 . The analysis of this homozygotic population 
would be helpful to understand the analysis of ~ for the heterogeneity population, which is 
presented in the next section. 
3 The Basic Reproductive Number 
3.1 The ~0 of the Complex Model 
As mentioned in [7] the reproductive number (~0 ) is the effected number of secondary cases 
produced by a typical infected individual during its entire period of infectiousness in a demo-
graphically steady susceptible population. Therefore, in order to study whether HIV will invade 
a population or stabilize over a given region we must investigate the dynamics of ~0 . 
We are now ready to move on and compute the reproductive number when treatment, educa-
tion and vaccination are applied to the population. To study the potential of disease spread-
ing, we shall compute the basic reproductive number, Ro as in Diekmann et al.( 1990), and 
Castillo-Chavez et al (forthcoming), which indicates whether disease may invade a population 
in demographic steady state when there is no disease present. The computation is done by 
linearizing our system (20) around the disease-free state and looking for conditions that guar-
antee the growth of the three infected classes, Ij as well as the three treated classes, Tj . 
The resulting 6-dimensional system is represented in the following form: 
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11 7]1 0 0 0 0 0 
12 0 7J2 0 0 0 0 
X= 13 D= 0 0 7]2 0 0 0 
T1 ' 0 0 0 CfJ1 0 0 
T2 0 0 0 0 (/J2 0 
T3 0 0 0 0 0 (/J3 
b171 71 b371 ab171 a71 ab371 
b172 72 b372 ab172 a72 ab372 
M= c/3 b173 73 b373 ab173 a73 ab373 
m1 0 0 0 0 0 
0 m2 0 0 0 0 
• 
0 0 m3 0 0 0 
with 
71 fn (Ds1 + DE1 + DvJ, 
72 = !12 (Ds1 + DE1 + DvJ + x!22(Ds2 + DE2 + DvJ, 
73 !13 (Ds1 + DE1 + Dvl) + xh3(Ds2 + DE2 + Dv2), 
(/Ji = J-L + Y"fi, 
7Ji = p, + mi + 'Yi 
The six eigenvalues of the matrix MD-1 are 0, 0, 0, 0, ).._ and )..+, which are given by 
where 
(26) 
• 
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and 
(27) 
Because all elements on the right hand side of,\+ are positive, it is clear ,\+ > 0. Therefore, >.+ 
is the dominant eigenvalue of MD-I, which is also referred to the basic reproductive number, 
R0 (Diekmann et al. 1990). Further issues about R0 < 1 are discussed later when different 
cases are studied. The reproductive number for the complex model, R0 is a combination of 
the secondary infections caused by the infected and treated class. Notice that the square root 
denotes the 2 step process that a treated individual takes before s/he generates another treated 
person, (since when s/he infects a person the person must become infected first before s/he 
gets treated). 
3.2 Global Stability of Disease Free Equilibrium 
Here we define a Lyapunov function to prove that disease free equilibrium (DFE) is globally 
stable in the absence of an endemic equilibrium. 
Theorem 3.1 Suppose that 
(28) 
and 
(29) 
Then the disease-free equilibrium is globally stable . 
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Proof Let L = L_i(Ii + Tj) be a Lyapunov function. 
3 
L'(t) = L{(J.L+Y!'i)Tj- (J.L+/'j)Ij 
j=l 
Observe that the inequality (30) is true because ~ and 'l1 are positive. In addition by hy-
pothesis (28) and (29) we get L' < 0 for all j(=1,2,3), therefore the diseases-free equilibrium is 
globally stable. 
Note that if Ha < 1 where H3 = e++Y'Y3 , i. e~ the reduced infectivity "outweighs" the factor 
3 ~ ~ 
by which mortality is reduced for slow progressors, then (28) implies (29). 
Now will do some analysis of this reproductive number for the heterogeneity population. By 
plotting the reproductive number for the complex model, as a function of a and 'l1 and fixing 
the values for w = 1/60, and~ = .95, we obtained the following graph. Which describes the 
impact of education when the efficacy of education is between 0 and 1. 
As shown in figure 2(parts a, b), Ro < 1 as long as 'l1 (effectiveness of education) and a 
(the rate at which susceptibles go to the educated class) are not close to 0. This means that 
by educating some small portion of susceptible individuals will have some effect in reducing 
the generation of secondary newly infective persons, i.e R0 . Hence, education does reduce the 
reproductive number for the complex model. 
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Figure 2: Ro for education as function of Ill E (0, 1] and a E (0, oo) intercepted with Ro = 1 plane . 
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Figure 3: Ro for vaccine as function of~ E (0, 1] and wE (O,oo) intercepted with the plane Ro = 1 
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Then to see the impact of vaccination over the reproductive number, we graphed Reo as 
function of c; (effectiveness of the vaccine) and w (duration protection against HIV) and fixed 
a = 1/32 and c; = 0.95. Figure 3 (parts a, b) shows that ~0 < 1 if w is approximately 0, 
and c; is approaching to one. That is, the vaccine program is effective only when the vaccine 
is almost perfect and no individuals are losing their immunity to HIV, which implies that they 
will remain in the vaccinated class. However, this is unrealistic given that no vaccine is perfect, 
and individuals are only temporarily immune to the virus. 
3. 3 ~0 for different cases 
If mi is set to 0, which implies that no treatment is applied to the population, ~0 will be given 
by the following relation, 
~oJ = c [k1(!11{31 + !12{32 + !13(33) + xk2(!22{32 + h3{33)] 
ryl ry2 ry3 ry2 ry3 
(31) 
and the only thing that will change when either vaccination and education or both are applied 
is ki. 
Let us first consider the most simple case, which is when only three susceptible classes S1, 
S2 and S3 and the three infected classes 11, 12 and 13 are taken into consideration. Then, ki 
will be denoted by 
(32) 
thus, ~oJ is given by the sum of the secondary infections caused by each of the infected classes 
contained in our model. 
Now, if only vaccination is applied to the population, then ki will be given by 
ki = 9i(1- e-11 -PiE) 
11+w 
(33) 
~0 will be reduced based on the fact that ki is being multiplied by a factor which is always 
less than 1. This factor is denoted by reduction term due to the vaccine, and depends on the 
efficacy of the vaccine and number of people who were vaccinated. 
If only education is applied to the population, then ki will take the following form 
a 
ki = 9i(1 - --w) 
11+a 
(34) 
if we require that the education is effective in the population level to slow the spread of the 
disease, then one would expect that ki < 1. Notice that for any values of 11 and a, ki is always 
less than 1, thus, education will reduce ~0 . 
Now, if we compare the ki's of vaccination and education respectively to analyze which of 
the two have the most effect on the population, we get the following relation 
15 
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which indicates that it is better to apply education than vaccination. Otherwise, vaccination 
would be better, however, this is very unlikely to happen since we will be requiring that the 
efficacy of the vaccine is almost perfect and we know that all vaccines available only provide 
temporary immunity. 
If both vaccination and education are applied to the population, then the value of ki is given 
by (27). The joint intervention of treatment and vaccination will reduce the basic reproductive 
number more than if one or the other are applied. Now, if we wanted to determine which of 
the two has the most effect in the reduction of R0 , we compared their respective k~s and by 
doing so we get 
this inequality implies that education will have a greater impact than vaccination when both 
are present in the population, otherwise vaccination will have a greater effect. 
3.4 The ~0 for the SIT, VSIT and SIET Models 
When treatment is applied to the population, the basic reproductive number denoted by RoT 
with T indicating treatment, is 
(35) 
where 
(36) 
In a similar manner as studied in the previous section, we will present the reproductive 
number when treatment is present for different cases and again the only thing that will change 
for each case are the ki. Then, an analysis of how treatment affects R0T will be given. 
If only susceptibles, infecteds and treateds are considered, then ki will be 9i· Notice that 
the square root appears in RoT when treatment is present due to the two step processes that a 
treated individual takes before s/he can generate another treated. 
Now, when vaccination is added to the previous case ki will be given by (33). In this case 
we see that RoT will be reduced by this factor and by the contribution of treatment which will 
be presented in the next section. 
When education is introduced into the system in addition to treatment ki, are denoted by 
(34). RoT is reduced by the factor of ki and the contribution of treatment. 
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To examine the effectiveness of treatment not only in the individual level, but also in the 
population level to slow down the spread of the disease we took the partial derivatives of War 
with respect to mi and look for conditions under which the derivatives are less than 0. 
For convenience let, 
F1 ckdn/31 
F2 c(kd12 + xkd22)f32 
F3 c(kd13 + xkd23)f33 
Now, by taking the partial derivative of Wor with respect to m 1 we get 
{)~ 
After some simplifications and by setting , Dr < 0 we obtain the following, 
um1 
hence, 
(38) 
where 
H· = J-L+!iY 
J (p, + /j) (39) 
Likewise 
( 40) 
( 41) 
note 
/i Hi= 1- (1- y)-- so /i < !i {::=::?Hi> Hi 
fJ, + 'Yi 
by assumption of (2) we have H1 < H2 < H3 . 
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Now define 
note that 
is independent of all m1, m2, ma. 
Thus fori =F j, 
hence, 
also note 
1 
hii = --
J..t+li 
h~l = 0, h~2 < 0, h~3 < 0, 
h~l > 0, h~2 = 0, h~3 < 0, 
h~1 > O,h~2 > O,h~3 = 0 
l. h ( ) Hi 1 1m ij mj =---
m;->oo Hj J..t + /j 
(42) 
Therefore, if no treatment program is currently in effect, i.e, m1 = m2 = m3 = 0, then small 
increase in any or all the mi will reduce ~0 , i.e, 
a~ 
-a (o,o,o) < o 
ml 
a~ 
-a (o,o,o) < o 
m2 
(43) 
a~ 
-a (o,o,o) < o 
ma 
if the following inequality obtained from (38)-( 40) and ( 41) is satisfied: 
(44) 
If some treatment is already in effect, i.e., m1 + m2 + m3 > 0 then changes in the ffii will 
reduce ~oT if and only if the appropriate one(s) of the conditions in (43) hold for the current 
values of m1,m2 and ma . 
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Now, if we want to ensure that increments in any mi will reduce RoT regardless of the 
current values for m1, m2 , m3 , then we must have 
H F. (-1- fu_l_ fu_1_) 
1 J.t+'Yl ' H2 J.t+'Y2 ' H3 J.t+'Y3 ' 
a< min HF ( 1 1 & 1 ) 2 . J.t+'Yl' J.t+'Y2' H3 J.t+'Y3 ' 
A sufficient but not necessary condition to make this happen is 
(45) 
since ~~ is the smallest of the fractions above. Basically, the infectivity should be reduced at 
least as much as the lifespan is prolonged, with respect to R0 (0). 
Based on the previous results we can see that if both vaccination and treatment are applied 
to the population, the basic reproductive number denoted by RoT (35)with ki given by (33) will 
be reduced if the above inequalities are satisfied. However, reduction of RoT does not guarantee 
extinction of the disease, since both vaccination and treatment are not completely effective 
and does not give immunity nor eradicate the HIV respectively. Furthermore, if education and 
treatment are applied to the population, the basic reproductive number denoted by RoT (35) 
and ki given by (34) will be reduced . 
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4 Conclusion 
We have presented a novel model to incorporate genetic heterogeneity into HIV /AIDS epidemi-
ology. The basic reproductive number for this model was derived and the relative contributions 
from different cases were discussed. Our results support the conclusions of Shu-Fang Hsu 
Schmitz that some integrated intervention strategies (i.e., vaccination and treatment) are far 
superior to those based on a single approach. The secondary cases produced by the infected-
treated individuals is reduced the most when vaccination, education and treatment are applied 
to the population. However, education is the most effective in reducing the ~0 without having 
to fulfill any conditions and/or restrictions. This is because education is more reliable and it is 
always better to educate than not to. This is not only supported by our deterministic analysis 
but by the graphical analysis too. This analysis tell us that if we at least effectively educated 
some small portion of the suceptible individuals this will reduce the generation of secondary 
infections. In addition, by deterministic analysis we concluded that vaccination will make a 
difference only if it takes and gives immunity to the susceptible individuals for a longer period 
of time. The graphical analysis shows that the vaccine program would be effective only when 
the vaccine is almost perfect and none of the vaccinated individuals are losing their immunity 
to HIV. In the case of treatment, 'a', the reduction factor for infectivity must be really small in 
order for the treatment to reduce the value of ~0 . Treatment will reduce ~0 if the infectivity 
is reduced at least as much as the lifespan is prolonged. Therefore, the education program 
is a good option in reducing the number of secondary cases produced by the infected-treated 
individuals, not only because it is less costly at the individual and population level, but because 
in the long run people can get a lot more from education than from temporary vaccines and 
treatment. Nevertheless reduction in ~0 from the three different therapeutic approaches to HIV 
will not guarantee eradication of HIV, since both vaccines and treatment are not completely 
effective in reducing the infectivity rate. First, because vaccines are temporary and scientists 
have not developed an everlasting vaccine in way that would lower the number of HIV infec-
tion, and antiviral drugs used in treatment is not 100% effective because after some time the 
virus can still replicate even in the presence of these drugs. Likewise, even though education 
has the most impact in reducing the ~0 , effectively educating individuals does not mean these 
individuals will not get infected. It just means that these individuals will help in reducing the 
spread of the disease. Thus, the spread of the disease will continue to grow, or at least be 
control since up until now there is no cure for HIV. 
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